Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

Share Price is delayed by 15 minutes
Get Live Data
569.80    14.40 (2.59%)
Bid:
570.20
Ask:
570.60
Spread: 0.40 (0.07%)
Market Cap: £3.65b
ENT Live PriceLast checked at - London Stock Exchange

Intraday Entain Share Chart

Form 8.3 - Entain Plc

30 Sep 2021 13:51

RNS Number : 5931N
BNP Paribas London
30 September 2021
Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

Β 

1.

KEY INFORMATION

Β 

Β (a) Full name of discloser:

Β 

BNP Paribas SA

Β (b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Β 

Β (c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Entain plc

Β (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Β 

Β (e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

29/09/2021

Β (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes: DraftKings Inc

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

EUR 0.01 ordinary (IM00B5VQMV65)

Β 

Β 

Β 

Interests

Β 

Short Positions

Β 

Β 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,169,396

.20

-685,791

-.12

(2) Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

TOTAL:

1,169,396

.20

-685,791

-.12

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b)

Rights to subscribe for new securities (including directors'' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a)

Purchases and sales

Β 

Class of relevant

security

Purchase/sale

Number of

securities

Price per unit

IM00B5VQMV65

Purchase

301

21.5700 GBP

IM00B5VQMV65

Purchase

521

21.6101 GBP

IM00B5VQMV65

Purchase

755

21.6200 GBP

IM00B5VQMV65

Purchase

232

21.6300 GBP

IM00B5VQMV65

Purchase

1645

21.6415 GBP

IM00B5VQMV65

Purchase

1645

21.6415 GBP

IM00B5VQMV65

Purchase

3091

21.6500 GBP

IM00B5VQMV65

Purchase

110

21.6550 GBP

IM00B5VQMV65

Purchase

40

21.6600 GBP

IM00B5VQMV65

Purchase

141

21.6850 GBP

IM00B5VQMV65

Purchase

9

21.6900 GBP

IM00B5VQMV65

Purchase

196

21.7100 GBP

IM00B5VQMV65

Purchase

7

22.1200 GBP

IM00B5VQMV65

Sale

-350

21.6100 GBP

IM00B5VQMV65

Sale

-521

21.6101 GBP

IM00B5VQMV65

Sale

-521

21.6101 GBP

IM00B5VQMV65

Sale

-47

21.6300 GBP

IM00B5VQMV65

Sale

-368

21.6400 GBP

IM00B5VQMV65

Sale

-1645

21.6415 GBP

IM00B5VQMV65

Sale

-8399

21.6500 GBP

IM00B5VQMV65

Sale

-129

21.6600 GBP

IM00B5VQMV65

Sale

-37

21.6700 GBP

IM00B5VQMV65

Sale

-236

21.6900 GBP

IM00B5VQMV65

Sale

-39

21.7100 GBP

IM00B5VQMV65

Sale

-214

21.7300 GBP

IM00B5VQMV65

Sale

-40

21.7400 GBP

IM00B5VQMV65

Sale

-63

21.7500 GBP

IM00B5VQMV65

Sale

-140

21.7700 GBP

IM00B5VQMV65

Sale

-777

21.8000 GBP

IM00B5VQMV65

Sale

-167

21.8100 GBP

IM00B5VQMV65

Sale

-786

21.8200 GBP

IM00B5VQMV65

Sale

-148

21.8300 GBP

IM00B5VQMV65

Sale

-3

21.8900 GBP

IM00B5VQMV65

Sale

-231

21.9000 GBP

IM00B5VQMV65

Sale

-124

21.9200 GBP

IM00B5VQMV65

Sale

-114

21.9300 GBP

IM00B5VQMV65

Sale

-115

21.9500 GBP

IM00B5VQMV65

Sale

-53

21.9600 GBP

IM00B5VQMV65

Sale

-37

21.9700 GBP

IM00B5VQMV65

Sale

-3

21.9800 GBP

IM00B5VQMV65

Sale

-467

22.0000 GBP

IM00B5VQMV65

Sale

-731

22.0100 GBP

IM00B5VQMV65

Sale

-1623

22.0200 GBP

IM00B5VQMV65

Sale

-153

22.0300 GBP

IM00B5VQMV65

Sale

-186

22.0600 GBP

IM00B5VQMV65

Sale

-85

22.1100 GBP

IM00B5VQMV65

Sale

-179

22.1400 GBP

IM00B5VQMV65

Sale

-797

22.1500 GBP

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

relevant

security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a

long/short position

increasing/reducing a

long/short position

Number of

references

securities

Price per

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

of

relevant

security

Product

description

e.g. call

option

Writing,

purchasing,

selling,

varying etc.

Number

of

securities

to which

option

relates

Exercise

price

per unit

Type

e.g.

American

European

etc.

Expiry

date

Option

money

paid/

received

per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Class of

relevant

security

Product

description

e.g. call option

Exercising/

exercised

against

Number of

securities

Exercise price

per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if

applicable)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4.

Other Information

Β 

(a)

Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

(b)

Indemnity and other dealing arrangements

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

(c)

Attachments

Β 

Is a supplemental Form 8 (Open Positions) attached?

Β 

No

Β 

Β 

Date of Disclosure:

Β 

30/09/2021

Contact Name

Β 

Compliance Control Room

Telephone Number:

Β 

0207 595 9695

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETEAANEDLNFEFA
Date   Source Headline
8th Jun 20269:30 amRNSTR1: Notification of Major Holdings
2nd Jun 202610:12 amRNSTR1: Notification of Major Holdings
1st Jun 20267:01 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSIssuance of Shares
28th May 202612:00 pmRNSTR1: Notification of Major Holdings
28th May 202610:00 amRNSBoard Appointment
20th May 202610:01 amRNSTR1: Notification of Major Holdings
20th May 202610:00 amRNSTR1: Notification of Major Holdings
19th May 202610:00 amRNSTR1: Notification of Major Holdings
18th May 202610:00 amRNSTR1: Notification of Major Holdings
15th May 202610:00 amRNSTR1: Notification of Major Holdings
14th May 202612:34 pmRNSTR1: Notification of Major Holdings
13th May 202612:00 pmRNSTR1: Notification of Major Holdings
12th May 20264:01 pmRNSTR1: Notification of Major Holdings
5th May 20267:00 amRNSDirectorate Change
30th Apr 20261:29 pmRNSDirector/PDMR Shareholding
29th Apr 202611:54 amRNSResult of AGM
17th Apr 20269:58 amRNSTR1: Notification of Major Holdings
16th Apr 20262:01 pmRNSTR1: Notification of Major Holdings
16th Apr 20267:00 amRNSQ1 Trading Update
14th Apr 202612:00 pmRNSBetMGM Q1 2026 Update
7th Apr 20263:25 pmRNSDirector/PDMR Shareholding
1st Apr 20267:01 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSIssuance of Shares
20th Mar 202612:47 pmRNSAnnual Report and Notice of AGM
13th Mar 202610:38 amRNSTR1: Notification of Major Holdings
13th Mar 202610:38 amRNSTR1: Notification of Major Holdings
11th Mar 20262:17 pmRNSReleased in error
11th Mar 202612:36 pmRNSTR1: Notification of Major Holdings
11th Mar 20268:24 amRNSTR1: Notification of Major Holdings
9th Mar 20264:30 pmRNSTR1: Notification of Major Holdings
6th Mar 20262:03 pmRNSDirector/PDMR Shareholding
6th Mar 20269:36 amRNSTR1: Notification of Major Holdings
5th Mar 20267:00 amRNSFinal Results
24th Feb 20265:03 pmRNSTR1: Notification of Major Holdings
23rd Feb 202612:46 pmRNSTR1: Notification of Major Holdings
13th Feb 20267:00 amRNSTR1: Notification of Major Holdings
12th Feb 20267:00 amRNSTR1: Notification of Major Holdings
4th Feb 202612:00 pmRNSBetMGM FY 2025 Business Update
2nd Feb 20267:00 amRNSTotal Voting Rights
23rd Jan 20264:21 pmRNSTR1: Notification of Major Holdings
19th Jan 20261:42 pmRNSTR1: Notification of Major Holdings
5th Jan 20263:39 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:52 pmRNSTR1: Notification of Major Holdings
23rd Dec 20253:52 pmRNSTR1: Notification of Major Holdings
11th Dec 20257:00 amRNSGroup Chief Financial Officer succession
4th Dec 20258:42 amRNSTR1: Notification of Major Holdings
3rd Dec 20251:00 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20255:46 pmRNSStatement re increases to UK gambling taxes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.